Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1954 Jul 17;2(4880):122–126. doi: 10.1136/bmj.2.4880.122

Some Neurophysiological Aspects of Serotonin

D W Woolley, E Shaw
PMCID: PMC2079253  PMID: 13172487

Full text

PDF
122

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLASCHKO H. Amine oxidase and amine metabolism. Pharmacol Rev. 1952 Dec;4(4):415–458. [PubMed] [Google Scholar]
  2. COMROE J. H., Jr, VAN LINGEN B., STROUD R. C., RONCORONI A. Reflex and direct cardiopulmonary effects of 5-OH-tryptamine (serotonin); their possible role in pulmonary embolism and coronary thrombosis. Am J Physiol. 1953 Jun;173(3):379–386. doi: 10.1152/ajplegacy.1953.173.3.379. [DOI] [PubMed] [Google Scholar]
  3. ERSPAMER V., ASERO B. Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature. 1952 May 10;169(4306):800–801. doi: 10.1038/169800b0. [DOI] [PubMed] [Google Scholar]
  4. FELDBERG W., SHERWOOD S. L. Injections of drugs into the lateral ventricle of the cat. J Physiol. 1954 Jan;123(1):148–167. doi: 10.1113/jphysiol.1954.sp005040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GADDUM J. H., HEBB C. O., SILVER A., SWAN A. A. 5-Hydroxytryptamine; pharmacological action and destruction in perfused lungs. Q J Exp Physiol Cogn Med Sci. 1953;38(4):255–262. doi: 10.1113/expphysiol.1953.sp001037. [DOI] [PubMed] [Google Scholar]
  6. GINZEL K. H., KOTTEGODA S. R. The action of 5-hydroxytryptamine and tryptamine on aortic and carotid sinus receptors in the cat. J Physiol. 1954 Feb 26;123(2):277–288. doi: 10.1113/jphysiol.1954.sp005050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HOCH P. H., CATTELL J. P., PENNES H. H. Effects of mescaline and lysergic acid (d-LSD-25). Am J Psychiatry. 1952 Feb;108(8):579–584. doi: 10.1176/ajp.108.8.579. [DOI] [PubMed] [Google Scholar]
  8. MOSER M., SYNER J., MALITZ S., MATTINGLY T. W. Acute psychosis as a complication of hydralazine therapy in essential hypertension. J Am Med Assoc. 1953 Aug 1;152(14):1329–1331. doi: 10.1001/jama.1953.63690140001008. [DOI] [PubMed] [Google Scholar]
  9. PAGE I. H., MCCUBBIN J. W. The variable arterial pressure response to serotonin in laboratory animals and man. Circ Res. 1953 Jul;1(4):354–362. doi: 10.1161/01.res.1.4.354. [DOI] [PubMed] [Google Scholar]
  10. PAGE I. H. The vascular action of natural serotonin, 5- and 7-hydroxytryptamine and tryptamine. J Pharmacol Exp Ther. 1952 May;105(1):58–73. [PubMed] [Google Scholar]
  11. REID G. Circulatory effects of 5-hydroxytryptamine. J Physiol. 1952 Dec;118(4):435–453. doi: 10.1113/jphysiol.1952.sp004806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. REID G., RAND M. Pharmacological actions of synthetic 5-hydroxytryptamine (serotonin, thrombocytin). Nature. 1952 May 10;169(4306):801–802. doi: 10.1038/169801a0. [DOI] [PubMed] [Google Scholar]
  13. RINKEL M., DeSHON H. J., HYDE R. W., SOLOMON H. C. Experimental schizophrenia-like symptoms. Am J Psychiatry. 1952 Feb;108(8):572–578. doi: 10.1176/ajp.108.8.572. [DOI] [PubMed] [Google Scholar]
  14. SCHNEIDER J. A., YONKMAN F. F. Action of serotonin (5-hydroxytryptamine) on vagal afferent impulses in the cat. Am J Physiol. 1953 Jul;174(1):127–134. doi: 10.1152/ajplegacy.1953.174.1.127. [DOI] [PubMed] [Google Scholar]
  15. SHAW E., WOOLLEY D. W. Yohimbine and ergot alkaloids as naturally occurring antimetabolites of serotonin. J Biol Chem. 1953 Aug;203(2):979–989. [PubMed] [Google Scholar]
  16. TAYLOR R. D., PAGE I. H., CORCORAN A. C. A hormonal neurogenic vasopressor mechanism. AMA Arch Intern Med. 1951 Jul;88(1):1–8. doi: 10.1001/archinte.1951.03810070011001. [DOI] [PubMed] [Google Scholar]
  17. TWAROG B. M., PAGE I. H. Serotonin content of some mammalian tissues and urine and a method for its determination. Am J Physiol. 1953 Oct;175(1):157–161. doi: 10.1152/ajplegacy.1953.175.1.157. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES